These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9453760)

  • 21. Clopidogrel for preventing cardiovascular events.
    Stulman J; McGinn T; Korenstein D
    Mt Sinai J Med; 2009 Apr; 76(2):194-7. PubMed ID: 19306382
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypertension and associated diseases in elderly patients.
    Pathy SJ
    J Hypertens Suppl; 1988 Nov; 6(1):S37-40. PubMed ID: 3063791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary prevention in elderly survivors of heart attacks.
    Davenport J; Whittaker K
    Am Fam Physician; 1988 Jul; 38(1):216-24. PubMed ID: 2899386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study.
    Lanas F; Avezum A; Bautista LE; Diaz R; Luna M; Islam S; Yusuf S;
    Circulation; 2007 Mar; 115(9):1067-74. PubMed ID: 17339564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin and the risk of hemorrhagic stroke.
    Rosenberg R
    J Fam Pract; 1999 Mar; 48(3):169-70. PubMed ID: 10086752
    [No Abstract]   [Full Text] [Related]  

  • 26. Reducing the risk: heart disease, stroke and aspirin.
    Elwood PC
    J Med Assoc Thai; 2001 Aug; 84(8):1164-74. PubMed ID: 11758854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose aspirin for primary prevention of cardiovascular disease.
    Bredie SJ; Wollersheim H; Verheugt FW; Thien T
    Semin Vasc Med; 2003 May; 3(2):177-84. PubMed ID: 15199480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
    Migliaresi P; Celentano A; Palmieri V; Pezzullo S; Martino S; Bonito M; Guillaro B; Brancati C; Di Minno G
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):468-72. PubMed ID: 17379491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary stroke prevention.
    Rincon F; Sacco RL
    J Cardiovasc Nurs; 2008; 23(1):34-41; quiz 42-3. PubMed ID: 18158505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of effectiveness of intervention on risk factors for cerebrovascular disease in three cities of China].
    Liu YH; Yang QD; Zhu WB; Wang WZ; Wu SP; Hong Z; Xu HW; Zhou YH; Huang MS
    Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):105-8. PubMed ID: 12839661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes mellitus and stroke.
    Idris I; Thomson GA; Sharma JC
    Int J Clin Pract; 2006 Jan; 60(1):48-56. PubMed ID: 16409428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between chronic kidney disease prevalence and end-stage renal disease risk.
    Hallan SI; Vikse BE
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):286-91. PubMed ID: 18408480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentially modifiable classic risk factors and their impact on incident myocardial infarction: results from the EPIC-Potsdam study.
    Heidemann C; Hoffmann K; Klipstein-Grobusch K; Weikert C; Pischon T; Hense HW; Boeing H
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):65-71. PubMed ID: 17301629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The BC genotype of the VNTR polymorphism of platelet glycoprotein Ibalpha is overrepresented in patients with recurrent stroke regardless of aspirin therapy.
    Cervera A; Tàssies D; Obach V; Amaro S; Reverter JC; Chamorro A
    Cerebrovasc Dis; 2007; 24(2-3):242-6. PubMed ID: 17630485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Assessment of the budgetary impact of treatment guidelines in type II diabetes mellitus in France].
    Marissal JP; Sailly JC; Crainich D; Lebrun T
    Rev Epidemiol Sante Publique; 2005 Sep; 53 Spec No 1():1S67-78. PubMed ID: 16327742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to avoid a heart attack: putting it all together.
    Haffey TA
    J Am Osteopath Assoc; 2009 May; 109(5 Suppl):S14-20. PubMed ID: 19451253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The primary prevention of myocardial infarction.
    Manson JE; Tosteson H; Ridker PM; Satterfield S; Hebert P; O'Connor GT; Buring JE; Hennekens CH
    N Engl J Med; 1992 May; 326(21):1406-16. PubMed ID: 1533273
    [No Abstract]   [Full Text] [Related]  

  • 38. Joint recommendations on secondary prevention for persons with clinical coronary heart disease. International Society and Federation of Cardiology.
    Bol Asoc Med P R; 1985 Apr; 77(4):151-6. PubMed ID: 3859298
    [No Abstract]   [Full Text] [Related]  

  • 39. Long-term treatment of hypertensive with methyldopa. VI. Patient with target organ disease.
    Brest AN
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S109-13. PubMed ID: 6172666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevention of cardiovascular disease in the elderly].
    Belmin J
    Presse Med; 2000 Jun; 29(22):1234-9. PubMed ID: 10916537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.